Matabuena M., Salgado F.J., Nieto-Fontarigo J.J., Álvarez-Puebla M.J., Arismendi E., Barranco P., Bobolea I., Caballero M.L., Cañas J.A., Cárdaba B., Cruz M.J., Curto E., Domínguez-Ortega J., Luna J.A., Martínez-Rivera C., Mullol J., Muñoz X., Rodriguez-Garcia J., Olaguibel J.M., Picado C., Plaza V., Quirce S., Rial M.J., Romero-Mesones C., Sastre B., Soto-Retes L., Valero A., Valverde-Monge M., Del Pozo V., Sastre J., González-Barcala F.J.. Identification of Asthma Phenotypes in the Spanish MEGA Cohort Study Using Cluster Analysis. ARCHIVOS DE BRONCONEUMOLOGIA. 2023; 59(4)DOI:10.1016/j.arbres.2023.01.007. PMID:36732158. IF:8.700(Q1/1D).

Martinez-Garcia M.A., Guan W.-J., de-La-Rosa D., Athanazio R., Oscullo G., Shi M.-X., Pujal-Montaña P., Endlich B.N., Tiberi S., Centis R., Migliori G.B.. Post-TB bronchiectasis: from pathogenesis to rehabilitation. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE. 2023; 27(3)DOI:10.5588/ijtld.22.0566. PMID:36855043. IF:3.800(Q1/3D).

Sánchez-García S., Soto-Retes L., Chiner E., Cisneros C.. Remote visits for severe asthma patients after the COVID-19 pandemic: How to address the challenge?. REVISTA CLINICA ESPANOLA. 2023; 223(3)DOI:10.1016/j.rce.2023.01.009. PMID:36736728. IF:2.300(Q2/3D).

Company-Se G., Nescolarde L., Pajares V., Torrego A., Riu P.J., Rosell J., Bragós R.. Differentiation using minimally-invasive bioimpedance measurements of healthy and pathological lung tissue through bronchoscopy. Frontiers in Medicine. 2023; 10DOI:10.3389/fmed.2023.1108237. PMID:37113605. IF:3.100(Q1/2D).

Moya-Álvarez V., Castillo Villegas D., de Miguel Díez J.. Combined Pulmonary Fibrosis and Emphysema Syndrome: What is the Role of Airflow Limitation?. Open Respiratory Archives. 2023; 5(1)DOI:10.1016/j.opresp.2023.100233. PMID:37497242. IF:(Q/D).

Oscullo G., Gómez-Olivas J.D., Ingles M., Mompean S., Martinez-Perez R., Suarez-Cuartin G., Rosa-Carrillo D.L., Martinez-Garcia M.A.. Bronchiectasis-COPD Overlap Syndrome: Role of Peripheral Eosinophil Count and Inhaled Corticosteroid Treatment. Journal of Clinical Medicine. 2023; 12(19)DOI:10.3390/jcm12196417. PMID:37835060. IF:3.000(Q1/2D).

Perez de Llano L., Martínez Moragón E., Entrenas L.M., Martínez Rivera C., Cisneros C., Blanco-Aparicio M., Trisán A., Plaza V., Ramos J., Funenga Fitas E., Sanchez-Covisa J., Dominguez-Ortega J.. Validation of the Asthma Impairment and Risk Questionnaire in Spain: A Useful Tool for Assessing Asthma Control in Adolescents and Adults. JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY. 2023; 33(5)DOI:10.18176/jiaci.0881. PMID:36520522. IF:6.700(Q1/2D).

Franquet T., Giménez A., Mazzini S.. Pulmonary Complications Following Hematopoietic Stem Cell Transplantation: Radiological Considerations. Applied Psychology Readings: Selected Papers From The Singapore Conference On Applied Psychology 2022. 2023; DOI:10.1007/978-3-031-28797-8_6. PMID:. IF:(Q/D).

Figueira-Gonçalves, JM, García-Bello, MA, Ramallo-Fariña, Y, Méndez, R, Campos, AL, González-Jiménez, P, Peces-Barba, G, Molina-Molina, M, España, PP, García, E, Domínguez-Pazos, SD, Clemente, MG, Panadero, C, de la Rosa-Carrillo, D, Sibila, O, Martínez-Pitarch, MD, Toledo-Pons, N, López-Ramirez, C, Almonte-Batista, W, Macías-Paredes, A, Redenes-Bonet, D, Pérez-Rodas, EN, Lázaro, J, Fernández, SQ, Cordovilla, R, Cano-Pumarega, I, Torres, A, Menendez, R. Persistent Respiratory Failure and Re-Admission in Patients with Chronic Obstructive Pulmonary Disease Following Hospitalization for COVID-19. International Journal of Chronic Obstructive Pulmonary Disease. 2023; 18DOI:10.2147/COPD.S428316. PMID:37955022. IF:2.700(Q2/5D).

Barroso, B, Valverde-Monge, M, Alobid,, Olaguibel, J, Rial, M, Quirce, S, Arismendi, E, Barranco, P, Betancor, D, Bobolea,, Cardaba, B, Carmona, MC, Curto, E, Dominguez-Ortega, J, Gonzalez-Barcala, F, Martinez-Rivera, C, Mahillo-Fernandez,, Munoz, X, Picado, C, Plaza,, Munoz, JR, Retes, LS, Valero, A, Delpozo,, Mullol, J, Sastre, J. Reply to "Olfactory Function and Biologic Treatments: A Comment on Available Real-life Studies". JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY. 2023; 33(6)DOI:10.18176/jiaci.0953. PMID:38095497. IF:6.700(Q1/2D).

Berenguer J., Jarrín I., Bellón J.M., Díez C., Jiménez-Sousa M.A., Roca C., González-García J., Dalmau D., Olalla J., Herrero C., Villarroya F., Domingo P., Resino S.. Obesity-Related Single-Nucleotide Polymorphisms and Weight Gain following First-Line Antiretroviral Therapy. CLINICAL INFECTIOUS DISEASES. 2023; 76(6)DOI:10.1093/cid/ciac880. PMID:36345912. IF:(Q/D).

Martín-Iguacel R., Vazquez-Friol M.C., Burgos J., Bruguera A., Reyes-Urueña J., Moreno-Fornés S., Aceitón J., Díaz Y., Domingo P., Saumoy M., Knobel H., Dalmau D., Borjabad B., Johansen I.S., Miro J.M., Casabona J., Llibre J.M.. Cardiovascular events in delayed presentation of HIV: the prospective PISCIS cohort study. Frontiers in Medicine. 2023; 10DOI:10.3389/fmed.2023.1182359. PMID:37415770. IF:3.100(Q1/2D).

de Juan Bagudá J., de Frutos F., López-Vilella R., Couto Mallón D., Guzman-Bofarull J., Blazquez-Bermejo Z., Cobo-Belaustegui M., Mitroi C., Pastor-Pérez F.J., Moliner-Abós C., Rangel-Sousa D., Díaz-Molina B., Tobar-Ruiz J., Salterain Gonzalez N., García-Pinilla J.M., García-Cosío Carmena M.D., Crespo-Leiro M.G., Dobarro D., Almenar L., Delgado-Jiménez J.F., Paredes-Galán E., González-Vílchez F., González-Costello J.. Repetitive ambulatory levosimendan as a bridge to heart transplantation. REVISTA ESPANOLA DE CARDIOLOGIA. 2023; DOI:10.1016/j.recesp.2023.07.005. PMID:. IF:(Q/D).

Isla D., Felip E., Garrido P., Insa A., Majem M., Remon J., Trigo J.M., de Castro J.. A Delphi consensus panel about clinical management of early-stage EGFR-mutated non-small cell lung cancer (NSCLC) in Spain: a Delphi consensus panel study. Clinical & Translational Oncology. 2023; 25(1)DOI:10.1007/s12094-022-02941-5. PMID:36168085. IF:2.800(Q2/5D).

Peters S., Letovanec I., Mauer M., Dafni U., Ejedepang D., Biernat W., Bubendorf L., Warth A., Pokharel S., Reinmuth N., Tarruella, MM, Casas-Martin J., Tsourti Z., Marti N., Kammler R., Danson S., O'Brien M., Stahel R.A.. Assessment of RANK/RANK-L prevalence and clinical significance in NSCLC European Thoracic Oncology Platform Lungscape cohort and SPLENDOUR randomized clinical trial. LUNG CANCER. 2023; 175DOI:10.1016/j.lungcan.2022.12.004. PMID:36535121. IF:4.500(Q1/2D).

John T., Majem M., Legg D., Goldman J.. Current and Future Perspectives of Health-Related Quality of Life in Resectable EGFR-Mutated Non-Small Cell Lung Cancer: A Podcast. Targeted Oncology. 2023; 18(1)DOI:10.1007/s11523-022-00927-5. PMID:36534268. IF:4.400(Q2/3D).

Blakely C.M., Weder W., Bubendorf L., He J., Majem M., Shyr Y., Chaft J.E.. Primary endpoints to assess the efficacy of novel therapeutic approaches in epidermal growth factor receptor-mutated, surgically resectable non-small cell lung cancer: A review. LUNG CANCER. 2023; 177DOI:10.1016/j.lungcan.2023.01.002. PMID:36736076. IF:4.500(Q1/2D).

Vidal J., Fernández-Rodríguez M.C., Casadevall D., García-Alfonso P., Páez D., Guix M., Alonso V., Cano M.T., Santos C., Durán G., Elez E., Manzano J.L., Garcia-Carbonero R., Ferreiro R., Losa F., Pineda E., Sastre J., Rivera F., Bellosillo B., Tabernero J., Aranda E., Salazar R., Montagut C.. Liquid Biopsy Detects Early Molecular Response and Predicts Benefit to First-Line Chemotherapy plus Cetuximab in Metastatic Colorectal Cancer: PLATFORM-B Study. CLINICAL CANCER RESEARCH. 2023; 29(2)DOI:10.1158/1078-0432.CCR-22-1696. PMID:36074154. IF:10.400(Q1/1D).

Martinez D.A.S., Quilez-Cutillas A., Jimenez-Labaig P., Sesma A., Tarazona N., Pacheco-Barcia V., Obispo B., Paez D., Quintanar T., Sanchez-Canovas M., Montes A.F., Felip E., Rodriguez-Lescure A., Elez E.. Current professional standing of young medical oncologists in Spain: a nationwide survey by the Spanish Society of Medical Oncology + MIR section. Clinical & Translational Oncology. 2023; 25(3)DOI:10.1007/s12094-022-02989-3. PMID:36418642. IF:2.800(Q2/5D).

Karachaliou N., Codony-Servat J., Teixidó C., Pilotto S., Drozdowskyj A., Codony-Servat C., Giménez-Capitán A., Molina-Vila M.A., Bertrán-Alamillo J., Gervais R., Massuti B., Morán T., Majem M., Felip E., Carcereny E., García-Campelo R., Viteri S., González-Cao M., Morales-Espinosa D., Verlicchi A., Crisetti E., Chaib I., Santarpia M., Luis Ramírez J., Bosch-Barrera J., Felipe Cardona A., de Marinis F., López-Vivanco G., Miguel Sánchez J., Vergnenegre A., Sánchez Hernández J.J., Sperduti I., Bria E., Rosell R.. Author Correction: BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer (Scientific Reports, (2015), 5, 1, (17499), 10.1038/srep17499). Scientific Reports. 2023; 13(1)DOI:10.1038/s41598-023-30374-9. PMID:36869103. IF:3.800(Q1/2D).